PAAB is proposing to expand the types of evidence eligible for
supporting advertising claims related to healthcare
products.
Currently, the PAAB Code of Advertising Acceptance
(Code) requires that clinical or therapeutic claims in the
advertising and promotion of health care products be limited to
claims based on published, peer-reviewed, controlled and
well-designed clinical studies of specific patient populations,
such as randomized controlled clinical trials (RCTs). To a lesser
extent, high quality meta-analysis and observational studies may
sometimes be acceptable.
PAAB is now proposing to amend the Code to permit advertising
claims based on an expanded definition of clinical data, to include
data that is not derived from RCTs.